Overview

Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early Gout

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to assess the effect of febuxostat, once daily (QD), on joint damage in patients with elevated serum urate levels and gout.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Febuxostat